Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Tara Shochet"'
Autor:
Tara Shochet, Sara Larrea, Lucía Berro Pizzarossa, Kinga Jelinska, Jennifer Blum, Irina Sagaidac, Rodica Comendant
Publikováno v:
Gates Open Research, Vol 7 (2023)
Background: To better comprehend the demand for online medication abortion and to inform service delivery practice, we conducted an analysis of Women Help Women (WHW) service delivery statistics. The primary goals were to understand their user profil
Externí odkaz:
https://doaj.org/article/271da2dacda54322a15aa36ba693e323
Autor:
Courtney Kerestes, Rebecca Delafield, Jennifer Elia, Tara Shochet, Bliss Kaneshiro, Reni Soon
Publikováno v:
Perspectives on sexual and reproductive healthREFERENCES.
Direct-to-patient telemedicine abortion allows people to receive mifepristone and misoprostol for medication abortion in their home without requiring an in-person visit with a healthcare provider. This method has high efficacy and safety, but less is
Publikováno v:
Contraception. 122:109996
Autor:
Susan Haskell, Erica Chong, Kristina Tocce, Francine Thompson, Holly A. Anger, Esther Priegue, Joey Banks, Christy M. Boraas, Beverly Winikoff, Reni Soon, Leah Coplon, Tara Shochet, Shandhini Raidoo, Maureen K. Baldwin, Paula H. Bednarek, Ingrida Platais, Melissa Grant, Elizabeth G. Raymond
Publikováno v:
Contraception. 104:43-48
Objective To present updated evidence on the safety, efficacy and acceptability of a direct-to-patient telemedicine abortion service and describe how the service functioned during the COVID-19 pandemic. Study Design We offered the study at 10 sites t
Autor:
Holly A. Anger, Erica Chong, Leah Coplon, Sue Haskell, Maureen K. Baldwin, Paula H. Bednarek, Tara Shochet, Joey Banks, Kristina Tocce, Bliss Kaneshiro, Melissa Grant, Elizabeth G. Raymond, Christy M. Boraas, Ingrida Platais
Publikováno v:
Contraception. 103:400-403
To examine the proportion of high-sensitivity urine pregnancy test (HSPT) results that were positive by time after successful medication abortion.We used data from an ongoing study that provides mifepristone and misoprostol for medication abortion by
Autor:
Elizabeth G. Raymond, Alice Mark, Daniel Grossman, Anitra Beasley, Kristyn Brandi, Jen Castle, Mitchell D. Creinin, Caitlin Gerdts, Laura Gil, Melissa Grant, April Lockley, Jamila Perritt, Tara Shochet, Dominique Truan, Ushma D. Upadhyay
Publikováno v:
Contraception. 121:109998
Publikováno v:
Contraception. 110
We assessed whether a low-sensitivity pregnancy test is effective at identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.From October 2018 to March 2020, we performed a prospective observational study of participants
Autor:
Ingrida Platais, Christy M. Boraas, Holly A. Anger, Sue Haskell, Melissa Grant, Elizabeth G. Raymond, Joey Banks, Leah Coplon, Tara Shochet, Kristina Tocce, Beverly Winikoff
Publikováno v:
Contraception. 104(6)
Objectives To compare outcomes among patients who did or did not have pre-abortion ultrasound or pelvic exam before obtaining medication abortion (MA) via direct-to-patient telemedicine and mail. Study design We analyzed data from participants screen
Autor:
Seema Parvekar, Peter von Dadelszen, Beverly Winikoff, Thomas R. Easterling, Tara Shochet, Hillary Bracken, Laura A. Magee, Sulabha Mool, Shuchita Mundle
Publikováno v:
Easterling, T, Mundle, S, Bracken, H, Parvekar, S, Mool, S, Magee, L A, von Dadelszen, P, Shochet, T & Winikoff, B 2019, ' Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy : an open-label, randomised controlled trial ', The Lancet, vol. 394, no. 10203, pp. 1011-1021 . https://doi.org/10.1016/S0140-6736(19)31282-6
Background: Hypertension is the most common medical disorder in pregnancy, complicating one in ten pregnancies. Treatment of severely increased blood pressure is widely recommended to reduce the risk for maternal complications. Regimens for the acute
Publikováno v:
Contraception. 102(3)
Objective To explore hCG patterns using multi-level urine pregnancy tests (MLPTs) among prenatal clients to evaluate the potential use of these tests for medical abortion follow-up after 63 days’ gestation. Study design Prenatal clients with gestat